CDT Stock Risk & Deep Value Analysis
CDT Equity Inc
Healthcare • Biotechnology
DVR Score
out of 10
What You Need to Know About CDT Stock
We analyzed CDT Equity Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran CDT through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Extreme. Here's what we found.
How Risky Is CDT Stock?
Overall Risk
Extreme
Financial Risk
High
Market Risk
High
Competitive Risk
High
Execution Risk
High
Regulatory Risk
High
What Are the Red Flags for CDT?
- âš
Continued apparent defunct status/delisting
- âš
Official insolvency declaration
- âš
Irreversible data discrepancy confirmation
Unlock CDT Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does CDT Equity Inc (CDT) Do?
Market Cap
$1.98M
Sector
Healthcare
Industry
Biotechnology
Employees
6
CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Visit CDT Equity Inc WebsiteIs CDT Stock Undervalued?
Unlock the full AI analysis for CDT
Get the complete DVR score, risk analysis, and more
Does CDT Have a Competitive Moat?
Sign in to unlockMoat Rating
⚪ None
Moat Trend
Eroding
Moat Sources
1 Identified
No moat exists due to the apparent defunct status and lack of any operational business. Any prior competitive advantages would have eroded completely.
Moat Erosion Risks
- •Continued defunct status
- •Lack of any operational assets or revenue
CDT Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive CDT Stock Higher?
Near-Term (0-6 months)
- •N/A (No operational business or public disclosures to track for catalysts.)
Medium-Term (6-18 months)
- •N/A
Long-Term (18+ months)
- •N/A
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for CDT?
- ✓
Confirmation of company revival/relisting (highly improbable)
- ✓
Correction of market data indicating an active, publicly traded entity with a verifiable market capitalization
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for CDT (CDT Equity Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
